NYSE:MDTMedical Equipment
Medtronic (MDT) Stock Looks Reasonable Despite Its 26% Five Year Decline
Medtronic stock has delivered a decline of 26.0% over the past five years, yet its current checks point to a picture that is broadly in line with the intrinsic value estimate from a Discounted Cash Flow (DCF) model and an earnings multiple that screens as undervalued.
Over a 5 year window, Medtronic has fallen 26.0%, which puts more focus on whether the current price reflects a reset in expectations rather than clear upside.
Recent moves, including the SPR Therapeutics acquisition and...